Table of Contents Author Guidelines Submit a Manuscript
Cardiology Research and Practice
Volume 2013, Article ID 637482, 16 pages
http://dx.doi.org/10.1155/2013/637482
Review Article

Management Strategies in Cardiac Surgery for Postoperative Atrial Fibrillation: Contemporary Prophylaxis and Futuristic Anticoagulant Possibilities

Division of Cardiac Surgery, Brigham and Women’s Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA

Received 26 June 2013; Accepted 13 October 2013

Academic Editor: Gavin W. Lambert

Copyright © 2013 George Tokmaji et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Shrivastava, B. Smith, D. Caskey, and P. Reddy, “Atrial fibrillation after cardiac surgery: does prophylactic therapy decrease adverse outcomes associated with atrial fibrillation,” Journal of Intensive Care Medicine, vol. 24, no. 1, pp. 18–25, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Hakala, J. Halonen, K. Mäkinen, and J. Hartikainen, “Prevention of atrial fibrillation after cardiac surgery,” Scandinavian Journal of Surgery, vol. 102, no. 3, pp. 178–181, 2013. View at Google Scholar
  3. J. P. Mathew, M. L. Fontes, I. C. Tudor et al., “A multicenter risk index for atrial fibrillation after cardiac surgery,” The Journal of the American Medical Association, vol. 291, no. 14, pp. 1720–1729, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. E. L. Gillespie, C. M. White, J. Kluger, J. Sahni, R. Gallagher, and C. I. Coleman, “A hospital perspective on the cost-effectiveness of β-blockade for prophylaxis of atrial fibrillation after cardiothoracic surgery,” Clinical Therapeutics, vol. 27, no. 12, pp. 1963–1969, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. E. L. Gillespie, C. M. White, J. Kluger, J. A. Rancourt, R. Gallagher, and C. I. Coleman, “Cost-effectiveness of amiodarone for prophylaxis of atrial fibrillation after cardiothoracic surgery,” Pharmacotherapy, vol. 26, no. 4, pp. 499–504, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Filardo, C. Hamilton, R. F. Hebeler Jr., B. Hamman, and P. Grayburn, “New-onset postoperative atrial fibrillation after isolated coronary artery bypass graft surgery and long-term survival,” Circulation: Cardiovascular Quality and Outcomes, vol. 2, no. 3, pp. 164–169, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Bramer, A. H. M. van Straten, M. A. Soliman Hamad, E. Berreklouw, E. J. Martens, and J. G. Maessen, “The impact of preoperative atrial fibrillation on early and late mortality after coronary artery bypass grafting,” European Journal of Cardio-Thoracic Surgery, vol. 38, no. 3, pp. 373–379, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Kalavrouziotis, K. J. Buth, T. Vyas, and I. S. Ali, “Preoperative atrial fibrillation decreases event-free survival following cardiac surgery,” European Journal of Cardio-Thoracic Surgery, vol. 36, no. 2, pp. 293–299, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Schulenberg, P. Antonitsis, A. Stroebel, and S. Westaby, “Chronic atrial fibrillation is associated with reduced survival after aortic and double valve replacement,” Annals of Thoracic Surgery, vol. 89, no. 3, pp. 738–744, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. M. F. El-Chami, P. Kilgo, V. Thourani et al., “New-onset atrial fibrillation predicts long-term mortality after coronary artery bypass graft,” Journal of the American College of Cardiology, vol. 55, no. 13, pp. 1370–1376, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. J. L. Cox, “A perspective of postoperative atrial fibrillation in cardiac operations,” Annals of Thoracic Surgery, vol. 56, no. 3, pp. 405–409, 1993. View at Google Scholar · View at Scopus
  12. B. Aldhoon, V. Melenovský, P. Peichl, and J. Kautzner, “New insights into mechanisms of atrial fibrillation,” Physiological Research, vol. 59, no. 1, pp. 1–12, 2010. View at Google Scholar · View at Scopus
  13. S. Nattel, B. Burstein, and D. Dobrev, “Atrial remodeling and atrial fibrillation: mechanisms and implications,” Circulation. Arrhythmia and Electrophysiology, vol. 1, no. 1, pp. 62–73, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Jalife, “Déjà vu in the theories of atrial fibrillation dynamics,” Cardiovascular Research, vol. 89, no. 4, pp. 766–775, 2011. View at Google Scholar
  15. M. Haïssaguerre, P. Jaïs, D. C. Shah et al., “Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins,” The New England Journal of Medicine, vol. 339, no. 10, pp. 659–666, 1998. View at Google Scholar
  16. A. J. Workman, “Cardiac adrenergic control and atrial fibrillation,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 381, no. 3, pp. 235–249, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Ravelli and M. Allessie, “Effects of atrial dilatation on refractory period and vulnerability to atrial fibrillation in the isolated Langendorff-perfused rabbit heart,” Circulation, vol. 96, no. 5, pp. 1686–1695, 1997. View at Google Scholar · View at Scopus
  18. H. Calkins, R. El-Atassi, A. Leon et al., “Effect of the atrioventricular relationship on atrial refractoriness in humans,” Pacing and Clinical Electrophysiology, vol. 15, no. 5, pp. 771–778, 1992. View at Google Scholar · View at Scopus
  19. F. Nardi, M. Diena, P. P. Caimmi et al., “Relationship between left atrial volume and atrial fibrillation following coronary artery bypass grafting,” Journal of Cardiac Surgery, vol. 27, no. 1, pp. 128–135, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. J. S. Kalus, M. F. Caron, C. M. White et al., “Impact of fluid balance on incidence of atrial fibrillation after cardiothoracic surgery,” American Journal of Cardiology, vol. 94, no. 11, pp. 1423–1425, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Kaireviciute, A. D. Blann, B. Balakrishnan et al., “Characterisation and validity of inflammatory biomarkers in the prediction of post-operative atrial fibrillation in coronary artery disease patients,” Thrombosis and Haemostasis, vol. 104, no. 1, pp. 122–127, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. E. V. Tselentakis, E. Woodford, J. Chandy, G. R. Gaudette, and A. E. Saltman, “Inflammation effects on the electrical properties of atrial tissue and inducibility of postoperative atrial fibrillation,” Journal of Surgical Research, vol. 135, no. 1, pp. 68–75, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. S. F. Aranki, D. P. Shaw, D. H. Adams et al., “Predictors of atrial fibrillation after coronary artery surgery: current trends and impact on hospital resources,” Circulation, vol. 94, no. 3, pp. 390–397, 1996. View at Google Scholar · View at Scopus
  24. J. Afilalo, M. Rasti, S. M. Ohayon, A. Shimony, and M. J. Eisenberg, “Off-pump vs. on-pump coronary artery bypass surgery: an updated meta-analysis and meta-regression of randomized trials,” European Heart Journal, vol. 33, no. 10, pp. 1257–1267, 2012. View at Google Scholar
  25. L. L. Creswell, J. C. Alexander Jr., T. B. Ferguson Jr., A. Lisbon, and L. A. Fleisher, “Intraoperative interventions: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery,” Chest, vol. 128, no. 2, supplement, pp. 28S–35S, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. G. D. Angelini, W. J. Penny, F. El-Ghamary et al., “The incidence and significance of early pericardial effusion after open heart surgery,” European Journal of Cardio-Thoracic Surgery, vol. 1, no. 3, pp. 165–168, 1987. View at Google Scholar · View at Scopus
  27. A. J. Bryan and G. D. Angelini, “Pericardial effusion after open heart surgery,” Thorax, vol. 45, no. 9, pp. 655–656, 1990. View at Google Scholar · View at Scopus
  28. E. Thorén, L. Hellgren, L. Jidéus, and E. Ståhle, “Prediction of postoperative atrial fibrillation in a large coronary artery bypass grafting cohort,” Interactive CardioVascular and Thoracic Surgery, vol. 14, no. 5, pp. 588–593, 2012. View at Google Scholar
  29. A. G. Zaman, R. A. Archbold, G. Helft, E. A. Paul, N. P. Curzen, and P. G. Mills, “Atrial fibrillation after coronary artery bypass surgery: a model for preoperative risk stratification,” Circulation, vol. 101, no. 12, pp. 1403–1408, 2000. View at Google Scholar · View at Scopus
  30. R. P. Villareal, R. Hariharan, B. C. Liu et al., “Postoperative atrial fibrillation and mortality after coronary artery bypass surgery,” Journal of the American College of Cardiology, vol. 43, no. 5, pp. 742–748, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Sedrakyan, A. W. Wu, A. Parashar, E. B. Bass, and T. Treasure, “Off-pump surgery is associated with reduced occurrence of stroke and other morbidity as compared with traditional coronary artery bypass grafting: a meta-analysis of systematically reviewed trials,” Stroke, vol. 37, no. 11, pp. 2759–2769, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. D. C. Cheng, D. Bainbridge, J. E. Martin, and R. J. Novick, “Does off-pump coronary artery bypass reduce mortality, morbidity, and resource utilization when compared with conventional coronary artery bypass? A meta-analysis of randomized trials,” Anesthesiology, vol. 102, no. 1, pp. 188–203, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Lamy, P. J. Devereaux, D. Prabhakaran et al., “Off-pump or on-pump coronary-artery bypass grafting at 30 days,” The New England Journal of Medicine, vol. 366, no. 16, pp. 1489–1497, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. V. Fuster, L. E. Rydén, D. S. Cannom et al., “2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines,” Circulation, vol. 123, no. 10, pp. e269–e367, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. N. Sprigg, J. Selby, L. Fox, E. Berge, D. Whynes, and P. M. Bath, “Very low quality of life after acute stroke: data from the efficacy of nitric oxide in stroke trial,” Stroke, vol. 44, no. 12, pp. 3458–3462, 2013. View at Publisher · View at Google Scholar
  36. A. Saxena, D. T. Dinh, J. A. Smith, G. C. Shardey, C. M. Reid, and A. E. Newcomb, “Usefulness of postoperative atrial fibrillation as an independent predictor for worse early and late outcomes after isolated coronary artery bypass grafting (multicenter Australian study of 19,497 patients),” American Journal of Cardiology, vol. 109, no. 2, pp. 219–225, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. D. G. Wyse, A. L. Waldo, J. P. DiMarco et al., “A comparison of rate control and rhythm control in patients with atrial fibrillation,” The New England Journal of Medicine, vol. 347, no. 23, pp. 1825–1833, 2002. View at Google Scholar · View at Scopus
  38. A. E. Epstein, J. C. Alexander, D. D. Gutterman, W. Maisel, and J. M. Wharton, “Anticoagulation: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery,” Chest, vol. 128, no. 2, supplement, pp. 24S–27S, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. S. J. Connolly, M. D. Ezekowitz, S. Yusuf et al., “Dabigatran versus warfarin in patients with atrial fibrillation,” The New England Journal of Medicine, vol. 361, no. 12, pp. 1139–1151, 2009. View at Google Scholar
  40. L. S. Wann, A. B. Curtis, K. A. Ellenbogen et al., “2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on Dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines,” Circulation, vol. 123, no. 10, pp. 1144–1150, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. M. R. Patel, K. W. Mahaffey, J. Garg et al., “Rivaroxaban versus warfarin in nonvalvular atrial fibrillation,” The New England Journal of Medicine, vol. 365, no. 10, pp. 883–891, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. C. B. Granger, J. H. Alexander, and J. J. McMurray, “Apixaban versus warfarin in patients with atrial fibrillation,” The New England Journal of Medicine, vol. 365, no. 11, pp. 981–992, 2011. View at Google Scholar
  43. K. A. Arsenault, A. M. Yusuf, E. Crystal et al., “Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery,” The Cochrane Database of Systematic Reviews, vol. 1, Article ID CD003611, 2013. View at Publisher · View at Google Scholar
  44. F. Biancari and M. A. A. Mahar, “Meta-analysis of randomized trials on the efficacy of posterior pericardiotomy in preventing atrial fibrillation after coronary artery bypass surgery,” The Journal of Thoracic and Cardiovascular Surgery, vol. 139, no. 5, pp. 1158–1161, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. D. C. Burgess, M. J. Kilborn, and A. C. Keech, “Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a meta-analysis,” European Heart Journal, vol. 27, no. 23, pp. 2846–2857, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. M. F. Khan, C. S. Wendel, and M. R. Movahed, “Prevention of post-coronary artery bypass grafting (CABG) atrial fibrillation: efficacy of prophylactic beta-blockers in the modern era: a meta-analysis of latest randomized controlled trials,” Annals of Noninvasive Electrocardiology, vol. 18, no. 1, pp. 58–68, 2013. View at Publisher · View at Google Scholar
  47. S. Chatterjee, P. Sardar, D. Mukherjee, E. Lichstein, and S. Aikat, “Timing and route of amiodarone for prevention of postoperative atrial fibrillation after cardiac surgery: a network regression meta-analysi,” Pacing and Clinical Electrophysiology, vol. 36, no. 8, pp. 1017–1023, 2013. View at Publisher · View at Google Scholar
  48. N. Z. Kerin and S. Jacob, “The efficacy of sotalol in preventing postoperative atrial fibrillation: a meta-analysis,” American Journal of Medicine, vol. 124, no. 9, pp. 875.e1–875.e9, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. J. Shepherd, J. Jones, G. K. Frampton, L. Tanajewski, D. Turner, and A. Price, “Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation,” Health Technology Assessment, vol. 12, no. 28, pp. 3-4, 9–95, 2008. View at Google Scholar · View at Scopus
  50. O. J. Liakopoulos, E. W. Kuhn, I. Slottosch, G. Wassmer, and T. Wahlers, “Preoperative statin therapy for patients undergoing cardiac surgery,” The Cochrane Database of Systematic Reviews, vol. 4, Article ID CD008493, 2012. View at Google Scholar
  51. V. Chopra, D. H. Wesorick, J. B. Sussman et al., “Effect of perioperative statins on death, myocardial infarction, atrial fibrillation, and length of stay: a systematic review and meta-analysis,” Archives of Surgery, vol. 147, no. 2, pp. 181–189, 2012. View at Publisher · View at Google Scholar · View at Scopus
  52. W. T. Chen, G. M. Krishnan, N. Sood, J. Kluger, and C. I. Coleman, “Effect of statins on atrial fibrillation after cardiac surgery: a duration- and dose-response meta-analysis,” The Journal of Thoracic and Cardiovascular Surgery, vol. 140, no. 2, pp. 364–372, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. K. M. Ho and J. A. Tan, “Benefits and risks of corticosteroid prophylaxis in adult cardiac surgery a dose-response meta-analysis,” Circulation, vol. 119, no. 14, pp. 1853–1866, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. J. M. Dieleman, J. van Paassen, D. van Dijk et al., “Prophylactic corticosteroids for cardiopulmonary bypass in adults,” The Cochrane Database of Systematic Reviews, no. 5, Article ID CD005566, 2011. View at Google Scholar · View at Scopus
  55. J. M. Dieleman, A. P. Nierich, P. M. Rosseel et al., “Intraoperative high-dose dexamethasone for cardiac surgery: a randomized controlled trial,” The Journal of the American Medical Association, vol. 308, no. 17, pp. 1761–1767, 2012. View at Publisher · View at Google Scholar
  56. D. Mozaffarian, R. Marchioli, A. Macchia et al., “Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial,” The Journal of the American Medical Association, vol. 308, no. 19, pp. 2001–2011, 2012. View at Publisher · View at Google Scholar
  57. T. Liu, P. Korantzopoulos, M. Shehata, G. Li, X. Wang, and S. Kaul, “Prevention of atrial fibrillation with omega-3 fatty acids: a meta-analysis of randomised clinical trials,” Heart, vol. 97, no. 13, pp. 1034–1040, 2011. View at Publisher · View at Google Scholar · View at Scopus
  58. D. Mozaffarian, J. H. Wu, M. C. de Oliveira Otto et al., “Fish oil and post-operative atrial fibrillation: a meta-analysis of randomized controlled trials,” Journal of the American College of Cardiology, vol. 61, no. 21, pp. 2194–2196, 2013. View at Publisher · View at Google Scholar
  59. C. Yorgancioğlu, B. Farsak, H. Tokmakoğlu, and S. Günaydin, “An unusual experience with posterior pericardiotomy,” European Journal of Cardio-Thoracic Surgery, vol. 18, pp. 727–728, 2000. View at Google Scholar
  60. A. A. Patel, C. M. White, E. L. Gillespie, J. Kluger, and C. I. Coleman, “Safety of amiodarone in the prevention of postoperative atrial fibrillation: a meta-analysis,” American Journal of Health-System Pharmacy, vol. 63, no. 9, pp. 829–837, 2006. View at Publisher · View at Google Scholar · View at Scopus
  61. M. A. Arstall, J. T. Y. Hii, R. G. Lehman, and J. D. Horowitz, “Sotalol-induced torsade de pointes: management with magnesium infusion,” Postgraduate Medical Journal, vol. 68, no. 798, pp. 289–290, 1992. View at Google Scholar · View at Scopus
  62. M. J. Antonaccio, J. N. Lessem, and L. F. Soyka, “Sotalol, hypokalaemia, syncope, and torsade de pointes,” British Heart Journal, vol. 52, no. 3, pp. 358–359, 1984. View at Google Scholar · View at Scopus
  63. L. D. Hillis, P. K. Smith, J. L. Anderson et al., “2011 ACCF/AHA guideline for coronary artery bypass graft surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines,” Circulation, vol. 124, pp. e652–e735, 2011. View at Publisher · View at Google Scholar
  64. L. S. Aglio, G. G. Stanford, R. Maddi, J. L. Boyd III, S. Nussbaum, and B. Chernow, “Hypomagnesemia is common following cardiac surgery,” Journal of Cardiothoracic and Vascular Anesthesia, vol. 5, no. 3, pp. 201–208, 1991. View at Publisher · View at Google Scholar · View at Scopus
  65. J. V. Booth, B. Phillips-Bute, C. B. McCants et al., “Low serum magnesium level predicts major adverse cardiac events after coronary artery bypass graft surgery,” American Heart Journal, vol. 145, no. 6, pp. 1108–1113, 2003. View at Publisher · View at Google Scholar · View at Scopus
  66. L. M. Klevay and D. B. Milne, “Low dietary magnesium increases supraventricular ectopy,” American Journal of Clinical Nutrition, vol. 75, no. 3, pp. 550–554, 2002. View at Google Scholar · View at Scopus